ABSTRACT
Federated learning is a technique for training predictive models without sharing patient-level data, thus maintaining data security while allowing inter-institutional collaboration. We used federated learning to predict acute kidney injury within three and seven days of admission, using demographics, comorbidities, vital signs, and laboratory values, in 4029 adults hospitalized with COVID-19 at five sociodemographically diverse New York City hospitals, between March-October 2020. Prediction performance of federated models was generally higher than single-hospital models and was comparable to pooled-data models. In the first use-case in kidney disease, federated learning improved prediction of a common complication of COVID-19, while preserving data privacy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (U54 TR001433-05). GNN is also supported by R01DK127139, R01HL155915, and R56DK126930. FW would like to acknowledge the support from NSF 1750326 and NIH RF1AG072449.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai (IRB-20-03271).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Sources of support. This study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (U54 TR001433-05). GNN is also supported by R01DK127139, R01HL155915, and R56DK126930. FW would like to acknowledge the support from NSF 1750326 and NIH RF1AG072449.
Data Availability
This article is written following the TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines, which are further elaborated in Supplementary Table 3. Furthermore, we release all code used for building the classifier under the GPLv3 license in a public GitHub repository.
